TOMTOM NV (TOM2.AS)

NL0013332471 - Common Stock

5.7  -0.28 (-4.68%)

Fundamental Rating

3

Overall TOM2 gets a fundamental rating of 3 out of 10. We evaluated TOM2 against 95 industry peers in the Software industry. While TOM2 seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, TOM2 is valued expensive at the moment.



Quickly go to:

2

1. Profitability

1.1 Basic Checks

TOM2 had negative earnings in the past year.
TOM2 had a positive operating cash flow in the past year.
TOM2 had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: TOM2 reported negative operating cash flow in multiple years.

1.2 Ratios

TOM2 has a worse Return On Assets (-2.64%) than 70.93% of its industry peers.
The Return On Equity of TOM2 (-11.57%) is worse than 72.09% of its industry peers.
Industry RankSector Rank
ROA -2.64%
ROE -11.57%
ROIC N/A
ROA(3y)-8.66%
ROA(5y)-0.8%
ROE(3y)-32.17%
ROE(5y)-13.59%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 84.78%, TOM2 is in the better half of the industry, outperforming 77.91% of the companies in the same industry.
In the last couple of years the Gross Margin of TOM2 has grown nicely.
The Profit Margin and Operating Margin are not available for TOM2 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 84.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.89%
GM growth 5Y3.9%

More info and screens

5

2. Health

2.1 Basic Checks

TOM2 does not have a ROIC to compare to the WACC, probably because it is not profitable.
TOM2 has less shares outstanding than it did 1 year ago.
TOM2 has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, TOM2 has a worse debt to assets ratio.

2.2 Solvency

TOM2 has a debt to FCF ratio of 2.24. This is a good value and a sign of high solvency as TOM2 would need 2.24 years to pay back of all of its debts.
TOM2 has a Debt to FCF ratio of 2.24. This is in the better half of the industry: TOM2 outperforms 66.28% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that TOM2 is not too dependend on debt financing.
The Debt to Equity ratio of TOM2 (0.21) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 2.24
Altman-Z N/A
ROIC/WACCN/A
WACC7.06%

2.3 Liquidity

TOM2 has a Current Ratio of 1.67. This is a normal value and indicates that TOM2 is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.67, TOM2 is doing good in the industry, outperforming 62.79% of the companies in the same industry.
A Quick Ratio of 1.62 indicates that TOM2 should not have too much problems paying its short term obligations.
TOM2 has a Quick ratio of 1.62. This is in the better half of the industry: TOM2 outperforms 63.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.62

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 80.25% over the past year.
The Revenue has grown by 9.03% in the past year. This is quite good.
Measured over the past years, TOM2 shows a decrease in Revenue. The Revenue has been decreasing by -3.17% on average per year.
EPS 1Y (TTM)80.25%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-28.57%
Revenue 1Y (TTM)9.03%
Revenue growth 3Y3.45%
Revenue growth 5Y-3.17%
Revenue growth Q2Q3.14%

3.2 Future

Based on estimates for the next years, TOM2 will show a very strong growth in Earnings Per Share. The EPS will grow by 55.96% on average per year.
TOM2 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.90% yearly.
EPS Next Y109.14%
EPS Next 2Y84%
EPS Next 3Y55.96%
EPS Next 5YN/A
Revenue Next Year0.59%
Revenue Next 2Y4.44%
Revenue Next 3Y4.67%
Revenue Next 5Y5.9%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

TOM2 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 389.97, TOM2 can be considered very expensive at the moment.
TOM2's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. TOM2 is more expensive than 68.60% of the companies in the same industry.
TOM2 is valuated expensively when we compare the Price/Forward Earnings ratio to 21.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 389.97

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TOM2 is valued a bit cheaper than 67.44% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, TOM2 is valued a bit cheaper than 61.63% of the companies in the same industry.
Industry RankSector Rank
P/FCF 34.92
EV/EBITDA 10.23

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TOM2 does not grow enough to justify the current Price/Earnings ratio.
TOM2's earnings are expected to grow with 55.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y84%
EPS Next 3Y55.96%

More info and screens

0

5. Dividend

5.1 Amount

TOM2 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TOMTOM NV

AMS:TOM2 (4/19/2024, 5:35:15 PM)

5.7

-0.28 (-4.68%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap727.60M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 389.97
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.64%
ROE -11.57%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 84.78%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.67
Quick Ratio 1.62
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)80.25%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y109.14%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.03%
Revenue growth 3Y3.45%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y